van Eeghen Sarah A, Nokoff Natalie J, Vosters Taryn G, Oosterom-Eijmael Maartina J P, Cherney David Z I, van Valkengoed Irene G M, Choi Ye Ji, Pyle Laura, Bjornstad Petter, den Heijer Martin, van Raalte Daniël H
Department of Internal Medicine, Center of Expertise on Gender Dysphoria, Amsterdam University Medical Centers, Location VU Medical Center, Amsterdam, The Netherlands.
Department of Endocrinology and Metabolism, Amsterdam University Medical Center, Location VU Medical Center, Amsterdam, The Netherlands.
Clin J Am Soc Nephrol. 2024 Dec 13;20(2):301-10. doi: 10.2215/CJN.0000000642.
Sexual dimorphism plays an important role in the pathogenesis and progression of CKD. Men with CKD often exhibit faster kidney function decline, leading to higher rates of kidney failure and mortality compared with women. Studies suggest that sex hormones may influence this apparent dimorphism, although the mechanisms underlying these influences remain poorly understood. In this review, we first summarize recent findings on sex differences in the prevalence and progression of CKD. Subsequently, we will focus on ( 1 ) the role of sex hormones in these sex differences, ( 2 ) kidney structural and hemodynamic differences between men and women, ( 3 ) the influence of sex hormones on pathophysiological processes leading to kidney disease, including glomerular hyperfiltration and key pathways involved in kidney inflammation and fibrosis, and finally, focus on the consequences of the underrepresentation of women in clinical trials. Understanding these sex differences is critical for advancing precision medicine and improving outcomes for both men and women with CKD.
性别差异在慢性肾脏病(CKD)的发病机制和进展中起着重要作用。与女性相比,患有CKD的男性通常肾功能下降更快,导致肾衰竭和死亡率更高。研究表明,性激素可能影响这种明显的性别差异,尽管这些影响的潜在机制仍知之甚少。在本综述中,我们首先总结了关于CKD患病率和进展中性别差异的最新研究结果。随后,我们将重点关注:(1)性激素在这些性别差异中的作用;(2)男性和女性之间的肾脏结构和血流动力学差异;(3)性激素对导致肾脏疾病的病理生理过程的影响,包括肾小球高滤过以及肾脏炎症和纤维化所涉及的关键途径;最后,关注临床试验中女性代表性不足的后果。了解这些性别差异对于推进精准医学和改善CKD男性和女性的治疗结果至关重要。